
Developing blood biomarkers to diagnose Alzheimer’s disease
Benefits for diagnostics and research When blood biomarker tests for AD do become clinically available, unlike the current testing methods of expensive positron electron tomography (PET) imaging scans and invasive lumbar spine puncture for a cerebrospinal …